Scimago Lab
powered by Scopus
eISSN: 1941-5923
call: +1.631.629.4328
Mon-Fri 10 am - 2 pm EST


Medical Science Monitor Basic Research


Breast Metaplastic Squamous Cell Carcinoma Diagnosed with Fine Needle and Core Biopsy: A Case Study

Challenging differential diagnosis, Unusual or unexpected effect of treatment, Rare disease

Na Cha, Shiyu Wang, Ming Lv, Dong-Wei Wang, Xiao-Jie Zhang, Min Zheng, Li-Xiang Tian

China (mainland) Department of Pathology, Changchun Obstetrics-Gynecology Hospital, Changchun, Jilin, China (mainland)

Am J Case Rep 2018; 19:203-206

DOI: 10.12659/AJCR.907254

Available online: 2018-02-23

Published: 2018-02-23


BACKGROUND: Breast metaplastic squamous cell carcinoma (SCC) is a rare primary breast carcinoma, and overexpression of HER2 in this carcinoma is extremely uncommon.
CASE REPORT: We presented a case of a 48-year-old Asian female with breast metaplastic SCC. Fine needle aspiration biopsy (FNAB) and core needle biopsy (CNB) of the lesion were taken prior to surgical resection. FNAB smears demonstrated highly atypical squamous cells and a diagnosis positive for malignancy was rendered. CNB and a surgical resection specimen revealed invasive squamous carcinoma with keratin pearl formation and intercellular bridges. Further study demonstrated this was an unusual metaplastic SCC case with basal-HER2 (+) phenotype. HER2 has been linked to poor prognosis and response to therapy.
CONCLUSIONS: The pathological diagnosis of the breast metaplastic SCC was made initially by FNAB and CNB. Identification of basal-HER2 (+) phenotype was critical for selection of hormonal therapies and chemotherapy.

Keywords: Genes, erbB-2, Mass Behavior, Metaplasia, Neoplasms, Squamous Cell